Literature DB >> 8660041

The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas.

M Weinreb1, P J Day, F Niggli, J E Powell, F Raafat, P B Hesseling, J W Schneider, P S Hartley, F Tzortzatou-Stathopoulou, E R Khalek, A Mangoud, U R El-Safy, F Madanat, M Al Sheyyab, C Mpofu, T Revesz, R Rafii, K Tiedemann, K D Waters, J C Barrantes, A Nyongo, M S Riyat, J R Mann.   

Abstract

Recent studies have suggested that Epstein-Barr virus (EBV) may play a role in the aetiology of Hodgkin's disease. To determine the role of EBV in childhood Hodgkin's disease in different geographical areas, immunohistochemical staining and in situ hybridisation were used to analyse latent membrane protein 1 (LMP 1) and small nuclear non-transcribed RNAs (EBER-1) respectively. Testing for EBV within the Reed-Sternberg and Hodgkin's cells was carried out in childhood Hodgkin's disease from 10 different countries. The proportion of LMP 1 positive cases varied significantly, being 50% of cases from the United Kingdom (38/75), South Africa (9/18), Egypt (7/14), and Jordan (8/16), 60% from the United Arab Emirates (6/10), 70% from Australia (11/16), 81% from Costa Rica (34/42), 88% from Iran (7/8), 90% from Greece (20/22), and 100% of the 56 cases from Kenya. A sensitive polymerase chain reaction based EBV strain typing technique was established using archival tissues. EBV strain type 1 was shown to be predominant in childhood Hodgkin's disease from the United Kingdom, South Africa, Australia, and Greece. Type 2 was predominant in Egypt. EBV strain types 1 and 2 were both detected in some cases of childhood Hodgkin's disease in the United Kingdom, Costa Rica, and Kenya. The high incidence of EBV and the presence especially in developing countries of dual infection with both strain types 1 and 2 may reflect socioeconomic conditions leading to malnutrition induced immunological impairment. The possibility of HIV infection also needs to be explored.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660041      PMCID: PMC1511586          DOI: 10.1136/adc.74.1.27

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  25 in total

1.  Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.

Authors:  M Rowe; H S Evans; L S Young; K Hennessy; E Kieff; A B Rickinson
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

2.  Detection of a second widespread strain of Epstein-Barr virus.

Authors:  J W Sixbey; P Shirley; P J Chesney; D M Buntin; L Resnick
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

3.  Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.

Authors:  A B Rickinson; L S Young; M Rowe
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

Review 4.  The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease.

Authors:  G Khan; P J Coates
Journal:  J Pathol       Date:  1994-11       Impact factor: 7.996

5.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

6.  Epstein-Barr virus (EBV) latent membrane protein (LMP) in tumor cells of Hodgkin's disease in pediatric patients.

Authors:  M V Preciado; E De Matteo; B Diez; S Grinstein
Journal:  Med Pediatr Oncol       Date:  1995-01

7.  Co-existence of the A and B types of Epstein-Barr virus DNA in lymph node biopsies from Algerian patients with Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  M Bouzid; M I Belkaid; P Colonna; A M Bouguermouh; T Ooka
Journal:  Leukemia       Date:  1993-09       Impact factor: 11.528

8.  Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues.

Authors:  K L Chang; Y Y Chen; D Shibata; L M Weiss
Journal:  Diagn Mol Pathol       Date:  1992-12

9.  Hodgkin's disease.

Authors:  L J Medeiros; T C Greiner
Journal:  Cancer       Date:  1995-01-01       Impact factor: 6.860

10.  U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.

Authors:  T Dambaugh; K Hennessy; L Chamnankit; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more
  24 in total

Review 1.  Hodgkin's disease and the Epstein-Barr virus.

Authors:  K J Flavell; P G Murray
Journal:  Mol Pathol       Date:  2000-10

Review 2.  Epidemiology and pathologic features of Hodgkin lymphoma.

Authors:  Shin-ichi Nakatsuka; Katsuyuki Aozasa
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

3.  The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil.

Authors:  Iguaracyra Araujo; Achiléa Lisboa Bittencourt; Helenemarie S Barbosa; Eduardo Martins Netto; Núbia Mendonça; Hans-Dieter Foss; Michael Hummel; Harald Stein
Journal:  Virchows Arch       Date:  2006-08-01       Impact factor: 4.064

4.  Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases.

Authors:  M Engel; M F Essop; P Close; P Hartley; G Pallesen; C Sinclair-Smith
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

5.  Epstein-Barr virus and Hodgkin's lymphoma in Cairo, Egypt.

Authors:  Josée Audouin; Jacques Diebold; Bharat Nathwani; Elia Ishak; Kenneth Maclennan; Hans Konrad Mueller-Hermelink; James O Armitage; Dennis D Weisenburger
Journal:  J Hematop       Date:  2010-05-28       Impact factor: 0.196

6.  EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults.

Authors:  Alison R Huppmann; Alina Nicolae; Graham W Slack; Stefania Pittaluga; Theresa Davies-Hill; Judith A Ferry; Nancy Lee Harris; Elaine S Jaffe; Robert P Hasserjian
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

Review 7.  Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  A J Swerdlow
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

Review 8.  Cancer of childhood in sub-Saharan Africa.

Authors:  Cristina Stefan; Freddie Bray; Jacques Ferlay; Biying Liu; D Maxwell Parkin
Journal:  Ecancermedicalscience       Date:  2017-07-28

9.  Association of Hodgkin's lymphoma with Epstein Barr virus infection.

Authors:  Elmir Cickusić; Jasminka Mustedanagić-Mujanović; Ermina Iljazović; Zinaida Karasalihović; Ina Skaljić
Journal:  Bosn J Basic Med Sci       Date:  2007-02       Impact factor: 3.363

10.  Infection and cervical neoplasia: facts and fiction.

Authors:  Wael I Al-Daraji; John Hf Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.